Re-emergent tremor in Parkinson’s disease: Epidemiological and clinical features
Objective: To evaluate the prevalence and the clinical features of re-emergent tremor (RET) in a large sample of consecutive patients with Parkinson's disease (PD) and…Primidone-related connective tissue disorders in essential tremor
Objective: To present a case of Dupuytren's contracture (DC), Ledderhose's syndrome (LS), and Peyronie's disease (PD) in a patient with long term use of primidone…Impaired eye voice coordination in spinocerebellar degeneration while reading aloud
Objective: In order to elucidate the cause of the impaired reading performance. Background: Deficit in reading performance in patients with spinocerebellar degeneration (SCD) has been…Screening for SLC25A46 mutations in familial and sporadic ataxic patients
Objective: To identify possible mutations of the SLC25A46 gene in patients with various forms of ataxia. Background: Members of the solute carrier family 25 (SLC25)…Autosomal recessive ataxia due to ANO10 mutations; full and novel phenotypic data in an Irish pedigree
Objective: We report on a family with ataxia due to mutations in the ANO10 gene to provide comprehensive clinical and cognitive data on the associated…Clinical and imaging characteristics of spinocerebellar ataxia type 14 defined in a German multi-center sample
Objective: To give a concise description of clinical and imaging features of spinocerebellar ataxia type 14 (SCA14). Background: Since its genetic definition in 2003, the…A randomized double-blind placebo- and positive-controlled crossover study to evaluate the effects of single doses of SD-809 (deutetrabenazine) and tetrabenazine on the corrected QT interval
Objective: Evaluate the pharmacokinetics and pharmacodynamics (QTc) of SD-809 (deutetrabenazine) and tetrabenazine. Background: SD-809 is a VMAT-2 inhibitor in clinical development for treatment of hyperkinetic…Dysregulations of GABAergic neurotransmission in Huntington’s disease brain
Objective: To investigate (1) the expression of GABAA receptors and KCC2 in both Huntington's disease (HD) mouse models and patients and (2) the inhibitory effect…Enroll-HD: A global clinical research platform for Huntington’s disease
Objective: To provide an update on the global observational registry study of Huntington's disease (HD) included in Enroll-HD, a platform for HD clinical research. Background:…Brain network imaging findings in multiple system atrophy with cognitive decline
Objective: In this study we examined the voxel-based morphometry (VBM), diffusion tensor imaging (DTI), and resting functional MRI (rsfMRI) of the multiple system atrophy (MSA)…
- « Previous Page
- 1
- …
- 173
- 174
- 175
- 176
- 177
- …
- 207
- Next Page »